Investigation of the discrimination and characterization of blood serum structure in patients with opioid use disorder using IR spectroscopy and PCA-LDA analysis
Authors:
- 1 October 2020
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 190, 113553
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Biochemical assay and spectroscopic analysis of oxidative/antioxidative parameters in the blood and serum of substance use disorders patients. A methodological comparison studySpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2020
- Diagnosis of opioid use disorder with high sensitivity and specificity by advanced computational analysis of Fourier transform infrared spectroscopyInfrared Physics & Technology, 2020
- The role of zinc deficiency-induced changes in the phospholipid-protein balance of blood serum in animal depression model by Raman, FTIR and UV–vis spectroscopyBiomedicine & Pharmacotherapy, 2017
- Qualitative and quantitative changes in phospholipids and proteins investigated by spectroscopic techniques in animal depression modelSpectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2017
- A significant association between BDNF promoter methylation and the risk of drug addictionGene, 2016
- Vibrational spectroscopy of biofluids for disease screening or diagnosis: translation from the laboratory to a clinical settingJournal of Biophotonics, 2014
- Opium and Heroin Alter Biochemical Parameters of Human's SerumThe American Journal of Drug and Alcohol Abuse, 2010
- Human body fluid proteome analysisProteomics, 2006
- Co-occurrence of Abuse of Different Drugs in MenArchives of General Psychiatry, 1998
- Differential hemodynamic, metabolic and hormonal effects of morphine and morphine-6-glucuronideBrain Research, 1994